Protective and Therapeutic Efficacy of Hesperidin versus Cisplatin against Ehrlich Ascites Carcinoma-Induced Renal Damage in Mice

This study evaluates the antitumor efficacy of hesperidin (Hesp) versus cisplatin (Cis) in Ehrlich ascites carcinoma (EAC)-bearing mice, as well as its protective effect against Cis-triggered nephrotoxicity. Seventy female mice were allocated into control, Hesp, EAC, Hesp-protected, Hesp-treated, Ci...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nahed Saleh, Tamer Allam, Reda M. S. Korany, Abdelfattah M. Abdelfattah, Ahmed M. Omran, Mabrouk Attia Abd Eldaim, Aziza M. Hassan, Nermeen Borai El-Borai
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-02-01
Serie:	Pharmaceuticals
Soggetti:	Ehrlich ascites carcinoma hesperidin cisplatin carcinoembryonic antigen Ki-67 caspase-3
Accesso online:	https://www.mdpi.com/1424-8247/15/3/294
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!